Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
2.530
-0.080 (-3.07%)
Nov 21, 2024, 4:00 PM EST - Market closed
Vistagen Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Net Income | -39.57 | -29.36 | -59.25 | -47.76 | -17.93 | -20.77 | Upgrade
|
| Depreciation & Amortization | 0.6 | 0.57 | 0.53 | 0.71 | 0.48 | 0.1 | Upgrade
|
| Other Amortization | - | - | - | 0.23 | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.01 | 0.01 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 3.3 | 2.18 | 3.34 | 3.48 | 2.31 | 3.93 | Upgrade
|
| Other Operating Activities | - | - | 3.64 | - | - | 0.83 | Upgrade
|
| Change in Accounts Receivable | - | - | - | - | - | 0.3 | Upgrade
|
| Change in Accounts Payable | 2.93 | 0.52 | -0.93 | 1.69 | 0.05 | -0.39 | Upgrade
|
| Change in Unearned Revenue | 0.7 | 0.52 | 0.21 | -1 | 3.67 | - | Upgrade
|
| Change in Other Net Operating Assets | -1.3 | -0.25 | 2.76 | -2.6 | -0.64 | 0.25 | Upgrade
|
| Operating Cash Flow | -33.49 | -25.81 | -49.72 | -45.26 | -12.07 | -15.76 | Upgrade
|
| Capital Expenditures | -0.16 | -0.06 | -0.21 | -0.2 | -0.28 | - | Upgrade
|
| Cash Acquisitions | - | - | -0.53 | - | - | - | Upgrade
|
| Investing Cash Flow | -13.31 | -0.06 | -0.74 | -0.2 | -0.28 | - | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 0.22 | - | Upgrade
|
| Total Debt Issued | - | - | - | - | 0.22 | - | Upgrade
|
| Short-Term Debt Repaid | - | -0.99 | -1.03 | - | -0.6 | -0.29 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | -0 | -0 | -0 | Upgrade
|
| Total Debt Repaid | 0 | -0.99 | -1.03 | -0 | -0.61 | -0.3 | Upgrade
|
| Net Debt Issued (Repaid) | 0 | -0.99 | -1.03 | -0 | -0.38 | -0.3 | Upgrade
|
| Issuance of Common Stock | 129.47 | 129.39 | 0.17 | 10.49 | 114.48 | 4.01 | Upgrade
|
| Other Financing Activities | -36.03 | - | -0.17 | - | - | 0.3 | Upgrade
|
| Financing Cash Flow | 93.44 | 128.4 | -1.04 | 10.48 | 114.1 | 4.01 | Upgrade
|
| Net Cash Flow | 46.64 | 102.53 | -51.5 | -34.97 | 101.75 | -11.75 | Upgrade
|
| Free Cash Flow | -33.65 | -25.87 | -49.93 | -45.46 | -12.35 | -15.76 | Upgrade
|
| Free Cash Flow Margin | -3841.44% | -2431.77% | - | -4099.28% | -1133.45% | - | Upgrade
|
| Free Cash Flow Per Share | -1.11 | -1.34 | -7.17 | -6.89 | -4.30 | -10.78 | Upgrade
|
| Cash Interest Paid | - | - | - | - | 0.01 | 0.01 | Upgrade
|
| Cash Income Tax Paid | - | - | - | - | 0 | 0 | Upgrade
|
| Levered Free Cash Flow | -21.06 | -18 | -32.74 | -25.98 | -8.07 | -9.02 | Upgrade
|
| Unlevered Free Cash Flow | -21.06 | -18 | -32.74 | -26.21 | -8.06 | -9.01 | Upgrade
|
| Change in Net Working Capital | -3.71 | 0.05 | -0.64 | 0.34 | -0.64 | 0.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.